Register Now: From Clinical to Commercial: Accelerating ADC Late-Stage Development with Technology Innovation and Integrated Platform
News|Articles|December 30, 2024

Top 10 Video Interviews of 2024

Author(s)Susan Haigney

The BioPharm International editors present our most popular video interviews from 2024.

The editors of BioPharm International® had the fortunate opportunity to sit down with several subject matter experts from the biopharmaceutical industry in 2024, with topics ranging from cell and gene therapies, messenger RNA, quality management, bispecific antibodies, and more.

The following are some of our most watched video interviews from 2024:

For more video interviews, visit BioPharmInternational.com. Check back throughout 2025 for the latest conference coverage. In addition, our Ask the Expert video series can be found at https://www.biopharminternational.com/topic/ask-the-expert.


Related to this article

The BioPharm Brief: Cosentyx Approved in Polymyalgia Rheumatica, a Phase 3 Survival Win for an AML Vaccine, and $173 Million for In Vivo Bone Marrow Editing
FDA approves Novartis’ Cosentyx as the first anti-IL-17 biologic for polymyalgia rheumatica, SELLAS Life Sciences’ WT1-targeted peptide vaccine galinpepimut-S meets its overall survival primary endpoint in the phase 3 REGAL trial in AML, and Marrow Therapeutics launches with $173 million to develop bone marrow-targeted genetic medicines.